Rosiglitazone
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
Product Details
| Category |
API's & Drug Standards Cancer Research and Antivirals Diabetes Research |
|---|---|
| Price | POA |
| CAS Number | 122320-73-4 |
| Formula | C18H19N3O3S |
| Molecular Weight | 357.43 |
| Purity | 98.0% |
| Appearance | white to creamy white crystalline powder |
| Availability | In Stock |
| Storage Conditions | +4°C |
Product Enquiry
Send us your enquiry for Rosiglitazone. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Rosiglitazone email us and we will include your contribution on the website.
